Hospira recalls 2 drugs over sterility issues: 4 things to know

Hospira recalled one lot of Hydromorphone, a pain medication, and four lots of the blood pressure drug Levophed Thursday due to a potential lack of sterility assurance.

Here are four things to know.

1. Hospira issued the recall after discovering a damaged sterilizing filter for nitrogen was used during the drugs' manufacturing process.

2. The affected drugs were distributed to wholesalers and hospitals nationwide between May 2017 and July 2017.

3. Hospira, which Pfizer acquired in 2015, has not received any reports of patient injuries related to the recalled products and no microorganisms have been found in the product batches.

4. The drugmaker launched an investigation to determine how the manufacturing error occurred and will implement corrective actions.

More articles on supply chain:

McKesson donates $150k worth of medical supplies to Hurricane Harvey relief efforts
Teleflex to acquire NeoTract for up to $1.1B
6 FDA decisions to look for in September

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars